Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bliss GVS Pharma Limited (NSE: BLISSGVS), ISIN INE416D01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BLISSGVS last traded at ₹696.95 (+0.66%), with a 52-week range of ₹118.35 to ₹733.75 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 35.01%, FIIs 8.07%, DIIs 9.47%, mutual funds 0.26%.
EquiSense Score (ECS): 87/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.